PSORIASIS-TARGETS TH - Psoriasis-Targets and Therapy
Publications
- 2024
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries
Valencia López, M. J., Stephan, B., Meineke, A., Wolf, S., Thaci, D., Mrowietz, U., Andrees, V., Rustenbach, S. J., Reich, K., Thalmann, L., Bogena, H., Staubach, P., von Kiedrowski, R. M. & Augustin, M., 2024, In: PSORIASIS-TARGETS TH. 14, p. 29-38 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
Hampton, P., Borg, E., Hansen, J. B. & Augustin, M., 2021, In: PSORIASIS-TARGETS TH. 11, p. 123-131 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review